New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...
The global sales of microbial identification are estimated to be worth USD 4.69 billion in 2025 and anticipated to reach a ...
This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular innovation, today announced the official launch of ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...
New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of ...
Takara Bio Inc. announced Tuesday that it will begin developing reagents for "next-generation sequencing," which will allow large volumes of genetic information to be read rapidly, in collaboration ...
"These results are encouraging, highlighting TET2-mutated clonal hematopoiesis as a potential biomarker to select patients who are more likely to respond to immunotherapy," said Padmanee Sharma, M.D., ...
Twist Bioscience is advancing synthetic DNA manufacturing with innovation but remains at the lower end of its 52-week range.
ETH Zurich scientists have created “MetaGraph,” a revolutionary DNA search engine that functions like Google for genetic data. By compressing global genomic datasets by a factor of 300, it allows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback